Detalles de la búsqueda
1.
Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.
Diabetes Spectr
; 34(2): 184-189, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34149259
2.
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study.
Diabetes Spectr
; 34(4): 407-418, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866875
3.
Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making.
Clin Diabetes
; 38(5): 439-448, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33384469
4.
Using Flash Continuous Glucose Monitoring in Primary Practice.
Clin Diabetes
; 37(2): 150-161, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31057221
5.
A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes.
Clin Diabetes
; 37(1): 57-64, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705498
6.
Empowering Primary Care Practitioners to Lead in Diabetes Care and Management.
Clin Diabetes
; 41(3): 435-437, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37456086
7.
Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.
Diabetes Obes Metab
; 19(2): 228-238, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717130
8.
Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States.
Postgrad Med
; : 1-11, 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38712604
9.
Initiating GLP-1 Therapy in Combination with FreeStyle Libre Provides Greater Benefit Compared with GLP-1 Therapy Alone.
Diabetes Technol Ther
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669474
10.
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.
Diabetes Technol Ther
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758213
11.
Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?
Diabetes Technol Ther
; 25(S3): S48-S55, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306443
12.
Advancements in Diabetes Technology Are Outpacing the Evidence.
Diabetes Technol Ther
; 25(S3): S35-S41, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306447
13.
Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.
Diabetes Ther
; 14(7): 1111-1136, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209236
14.
Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective.
Adv Ther
; 40(1): 1-18, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36282450
15.
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.
Prog Cardiovasc Dis
; 79: 65-79, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178991
16.
Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.
J Manag Care Spec Pharm
; 28(6): 592-603, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352995
17.
Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment.
Diabetes Technol Ther
; 23(S3): S12-S18, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34546082
18.
Can therapies that target the incretin system improve our ability to treat type 2 diabetes?
J Natl Med Assoc
; 102(6): 511-23, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20575217
19.
Results of the Epidemiology of Diabetes Interventions and Complications Trial.
Clin Diabetes
; 33(3): 144-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26203207
20.
Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy.
Postgrad Med
; 132(sup2): 26-36, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32815423